MedDataX Logo

PASCAL Trabeculoplasty

NCT ID: NCT00804323

Last Updated: 2024-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-12-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Argon laser trabeculoplasty (ALT) with 100 ms pulses is an effective therapy for lowering intraocular pressure (IOP). Similar reductions in IOP have been achieved using ns (SLT) and microsecond (MLT) pulses, which produce less thermal damage to trabecular meshwork (TM). Lack of clinically visible changes may make the accurate alignment of subsequent pulses difficult. We describe a novel technique - Patterned Laser Trabeculoplasty (PLT) using the PASCAL Photocoagulator system, and its preliminary evaluation in patients with open angle glaucoma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Pascal Laser Trabeculoplaty

NCT00838721

Open Angle Glaucoma Ocular Hypertension
COMPLETED NA

The Efficacy of Selective Laser Trabeculoplasty

NCT00347893

Primary Open Angle Glaucoma Ocular Hypertension Pseudo-Exfoliative Glaucoma +1 more
UNKNOWN

Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angle Glaucoma

NCT01956942

Open Angle Glaucoma
COMPLETED NA

Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma

NCT02679482

Glaucoma, Open-Angle Glaucoma, Primary Open Angle Exfoliation Glaucoma +1 more
UNKNOWN

Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

NCT01788319

Open Angle Glaucoma
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Open-Angle Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Patients with open-angle glaucoma

Group Type EXPERIMENTAL

Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)

Intervention Type PROCEDURE

Pattern Scan Laser trabeculoplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)

Pattern Scan Laser trabeculoplasty

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-year-old patients
* Uncontrolled Open angle (Shaffer IV)
* No previous surgical trabeculoplasty or glaucoma surgery

Exclusion Criteria

* Patients not willing to participate
* Angle-closure glaucoma
* No clear optical media
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asociación para Evitar la Ceguera en México

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Felix Gil Carrasco, MD

Role: PRINCIPAL_INVESTIGATOR

Asociación para Evitar la Ceguera en México

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asociación para Evitar la Ceguera en México

Mexico City, Mexico City, Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APEC-041

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension
NCT01126203 COMPLETED PHASE3
Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation Glaucoma
NCT03483402 COMPLETED NA
IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients
NCT01886456 UNKNOWN NA
Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
NCT01645319 COMPLETED
Micropulsed Laser Trabeculoplasty Using Different Parameters
NCT04900142 UNKNOWN NA
External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma
NCT00443664 UNKNOWN EARLY_PHASE1
Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure
NCT02613013 UNKNOWN NA
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
NCT02327312 TERMINATED NA
Effects of Selective Laser Trabeculoplasty
NCT00986141 TERMINATED
Trabeculectomy Versus 2-iStent and Prostaglandin Study
NCT03274323 WITHDRAWN NA
A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients
NCT01687465 UNKNOWN PHASE3
Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma
NCT00980473 UNKNOWN PHASE3
Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma
NCT01004900 UNKNOWN PHASE3
Response to SLT vs. ALT in Patients Under 60 Years of Age
NCT01087684 COMPLETED NA
Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refractory Glaucoma
NCT04297930 COMPLETED
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
NCT07076303 RECRUITING
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
NCT06851546 COMPLETED NA
Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma
NCT01383525 COMPLETED NA
Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies
NCT02199158 COMPLETED NA
SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
NCT07152132 RECRUITING NA
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
NCT05159960 ENROLLING_BY_INVITATION NA
Prospective Evaluation of the Efficacy of Pascal Laser Iridotomy and Pascal Laser Peripheral Iridoplasty: A Pilot Study
NCT01020071 COMPLETED NA
Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
NCT06925477 ENROLLING_BY_INVITATION NA
Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery
NCT03201354 COMPLETED NA
Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients
NCT05654493 ACTIVE_NOT_RECRUITING NA